Publications
The Case for Manufacturing Drugs in the United States Goes Back 45 Years
June 9, 2025
The Bayh-Dole Act of 1980 requires inventions made wholly or in part with federal funding to be substantially manufactured in the United States. Asher M. Rubin and Cassidy A. Pomeroy-Carter discuss how the 1980 law intended to keep drug manufacturing in the United States.
Contacts
Baltimore
+1 410 559 2881Baltimore
2850 Quarry Lake Drive, Suite 301
Baltimore, MD 21209
Capabilities
Suggested News & Insights
Sidley Represents Sino Biopharm in an Exclusive License Agreement With AstraZenecaJuly 13, 2026Legal Implications in AI Development and Deployment: Training Data and Grounding DataJuly 9, 2026Sidley Represents Abbisko Therapeutics in Its US$1.9 Billion Strategic Collaboration With Eli Lilly and Co.July 2, 2026Sidley Advises on the Hong Kong IPO of Shenzhen Senior Technology MaterialJune 23, 2026Sidley Advises HJ Science on Its Successful Chapter 18A Listing in Hong KongJune 23, 2026Life Sciences Transactions Partners Lila Hope and Jennifer Raab Join Sidley, Accelerating Further Growth in Life Sciences and the Palo Alto OfficeJune 22, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory